Sebastian Grimm

Sebastian Grimm is an accomplished professional in the field of molecular biotechnology, currently serving as Associate Director and Head of Protein Engineering at Ichnos Sciences since March 2021, where responsibilities include leading the immunocytokine platform development. Prior to this role, Sebastian held several key positions, including Associate Director at Pieris Pharmaceuticals and Molecular Partners AG, focusing on T-cell engagers and relevant platform characterizations, contributing to scientific advances in immunotherapy. Sebastian's expertise encompasses ribosome display selections, high-quality target protein generation, and multivalent formatting of DARPins. Educationally, Sebastian holds a PhD in Molecular Biotechnology from KTH Royal Institute of Technology, alongside master's and bachelor's degrees from the Technical University of Munich.